87.82
+0.15(+0.17%)
Currency In USD
| Previous Close | 87.67 |
| Open | 87.88 |
| Day High | 87.91 |
| Day Low | 87.48 |
| 52-Week High | 94.09 |
| 52-Week Low | 83.3 |
| Volume | 30.25M |
| Average Volume | 33.09M |
| Market Cap | 46.69B |
| PE | -6.98 |
| EPS | -12.59 |
| Moving Average 50 Days | 88.63 |
| Moving Average 200 Days | 88.04 |
| Change | 0.15 |
If you invested $1000 in iShares 20+ Year Treasury Bond ETF (TLT) 10 years ago, it would be worth $889.59 as of January 14, 2026 at a share price of $87.82. Whereas If you bought $1000 worth of iShares 20+ Year Treasury Bond ETF (TLT) shares 5 years ago, it would be worth $650.18 as of January 14, 2026 at a share price of $87.82.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Theralase(R) Announces Brokered LIFE Financing to Further Advance its Phase II Non-Muscle Invasive Bladder Cancer Clinical Study
Newsfile
Nov 24, 2025 12:00 PM GMT
Toronto, Ontario--(Newsfile Corp. - November 24, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeuti